Jazz Pharmaceuticals: Sleepiness trials
The registry lists 10 Sleepiness studies with Jazz Pharmaceuticals as lead sponsor. 0 are open to participants now and 10 have results posted.
Phase 2 5Phase 3 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive SleepinessCompletedNCT03037203Phase 2Results posted
- Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in NarcolepsyCompletedNCT02806908Phase 2Results posted
- Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSACompletedNCT02806895Phase 2Results posted
- "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"CompletedNCT02348632Phase 3Results posted
- "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"CompletedNCT02348619Phase 3Results posted
- "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"CompletedNCT02348606Phase 3Results posted
- "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"CompletedNCT02348593Phase 3Results posted
- A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With NarcolepsyCompletedNCT01681121Phase 2Results posted
- A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime SleepinessCompletedNCT01485770Phase 2Results posted
- Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in NarcolepsyCompletedNCT00066170Phase 3Results posted